PAUL YOUNG: Open Payments
NPI 1750318598 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 70 payments from 15 companies in 2025. Trend: 2023 $648 · 2024 $928 · 2025 $1,424
Food & beverage: $1,424
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $325 |
| Neurocrine BioSciences, Inc. | 13 | $323 |
| Corium, LLC | 13 | $176 |
| HARMONY BIOSCIENCES LLC | 4 | $140 |
| E.R. Squibb & Sons, L.L.C. | 5 | $114 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| ABBVIE INC. | 3 | $68 |
| Tris Pharma Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Biogen, Inc. | 1 | $24 |
Products named: CAPLYTA, INGREZZA, Azstarys, WAKIX, COBENFY, Auvelity, VRAYLAR, REXULTI.
Industry payments across TX — which companies pay providers there.
